SANOFI EUR2 revenue for the last year amounted to 43.07 B EUR, the most of which — 37.89 B EUR — came from its highest performing source at the moment, Biopharma, the year earlier bringing 30.69 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought SANOFI EUR2 18.51 B EUR, and the year before that — 18.27 B EUR.